| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 06/02/2004 | EP1423356A2 Novel aminobenzoephenones |
| 06/02/2004 | EP1137738B1 Process for the recovery of low molecular weight phenols, furfural, furfuryl alcohol and/or cellulose or cellulose-rich residues |
| 06/02/2004 | CN1501921A Diamine, acid dianhydride, polyimide composition having reactive group obtained therefrom, and processes for producing these |
| 06/02/2004 | CN1500800A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV) |
| 06/02/2004 | CN1500773A Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 06/02/2004 | CN1500769A Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds |
| 06/02/2004 | CN1152107C Spiro compound and application as electric fluorescent material material thereof |
| 06/01/2004 | US6743939 Phenylheteroalkylamine derivatives |
| 06/01/2004 | US6743928 Process for the manufacture of furfural |
| 06/01/2004 | US6743921 Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1-yl)-1-propanol compounds |
| 06/01/2004 | US6743916 Reacting an acetylene compound in the presence of a titanium compound and grignard reagent to obtain organotitanium compound |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743564 A positive resist formulation consists of nitrile containing tert-amine compound, an organic solvent and a base resin having an acidic functional group which is protected with an acid labile group, a photoacid generator |
| 05/27/2004 | WO2004043942A1 Process for producing ϝ-jasmolactone |
| 05/27/2004 | WO2004043939A1 Amide compounds and methods of using the same |
| 05/27/2004 | WO2004043903A1 3-aryloxy/ thio-2, 3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake |
| 05/27/2004 | WO2004043592A1 Supported catalyst containing rhenium and method for hydrogenation of carbonyl compounds in liquid phase by means of said catalyst |
| 05/27/2004 | WO2004043392A2 Mucin synthesis inhibitors |
| 05/27/2004 | WO2004026816A8 Aromatic liver x-receptor modulators |
| 05/27/2004 | WO2003039549A3 Selective antibacterial agents |
| 05/27/2004 | US20040102645 Process for preparing R-(-)-carnitin from S-(-)-chlorosuccinic acid or from a derivative thereof |
| 05/27/2004 | US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease |
| 05/27/2004 | US20040102517 Novel1,2-diphenylethene derivatives for treatment of immune diseases |
| 05/27/2004 | US20040102497 Novel inhibitors of IMPDH enzyme |
| 05/27/2004 | US20040102488 Antiinflamamtory agents; autoimmune diseases; antiarthritic agents; anticancer agents; Alzheimer's disease |
| 05/27/2004 | US20040102480 Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 05/27/2004 | US20040102338 Liquid intermediates; easy handling; lube oil detergents and dispersants; pour point depressants; paper surface sizing agents |
| 05/27/2004 | US20040101523 Blocking biosynthesis of neurotransmitters; enzyme inhibitors; cardiovascular disorders |
| 05/27/2004 | DE10252281A1 Supported rhenium catalyst, useful for the production of tetrahydrofuran and gamma-butyrolactone by reduction of carbonyl compounds, contains a further Group 8 or 1b metal and is prepared using a bimetallic precursor compound |
| 05/27/2004 | CA2505557A1 Mucin synthesis inhibitors |
| 05/26/2004 | EP1422218A1 Antiviral agent |
| 05/26/2004 | EP1421081A1 Method of mycophenolate mofetil preparation |
| 05/26/2004 | EP1421071A2 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators |
| 05/26/2004 | EP1421063A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 05/26/2004 | EP1421061A1 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia |
| 05/26/2004 | EP1421056A1 (alpha)-haloenamine reagents |
| 05/26/2004 | EP1420784A1 Compounds effecting glucokinase |
| 05/26/2004 | EP1420774A1 Preparation and diabetic use of gibberellins |
| 05/26/2004 | EP1420761A2 Solid phase syntheis of salts of organic acid |
| 05/26/2004 | EP1303478B1 Process for the preparation of substituted octanoyl amides |
| 05/26/2004 | EP1137645B1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
| 05/26/2004 | EP1064255B1 A process for the manufacture of (2s,2'r,3'r)-2-(2,3-dicarboxylcyclopropyl)-glycine |
| 05/26/2004 | EP0935691B1 Optical brightening agent |
| 05/26/2004 | EP0623346B1 Inhibitor for metastasis of malignant tumor |
| 05/26/2004 | CN1500087A 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 05/26/2004 | CN1151125C Compounds and methods for treatment of cardiovascular, imflammatory and immune disorders |
| 05/25/2004 | US6740762 Process for ascorbic acids using alkaline earth silicate catalysts |
| 05/25/2004 | CA2267059C Sordarin derivatives |
| 05/25/2004 | CA2176587C Preparation of .gamma.-butyrolactone |
| 05/25/2004 | CA2168458C The preparation of 1,4-butanediol |
| 05/25/2004 | CA2081935C Anilide derivatives and their use for combating botrytis |
| 05/25/2004 | CA2048172C Substituted sulfonamids, preparation processes and drugs containing same |
| 05/21/2004 | WO2004042351A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041812A1 Therapeutic compounds and methods |
| 05/21/2004 | WO2004041803A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors |
| 05/21/2004 | WO2004041802A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041801A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041800A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041789A1 Compositions useful as inhibitors of jak and other protein kinases |
| 05/21/2004 | WO2004041266A1 Receptor function controlling agent |
| 05/21/2004 | WO2004041264A1 2-oxo-ethanesulfonamide derivates |
| 05/21/2004 | WO2004041256A2 Safe chemical uncouplers for the treatment of obesity |
| 05/21/2004 | WO2004041211A2 INHIBITORS OF β-SECRETASE, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF ALZHEIMER’S DISEASE OR MILD COGNITIVE IMPAIRMENT |
| 05/21/2004 | WO2004041201A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 05/21/2004 | WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2002060435A8 Cryptotanshinone for preventing and alleviating alzheimer's disease |
| 05/21/2004 | CA2506772A1 Compositions useful as inhibitors of jak and other protein kinases |
| 05/21/2004 | CA2505322A1 Receptor function regulator |
| 05/21/2004 | CA2504999A1 Therapeutic compounds and methods |
| 05/21/2004 | CA2504344A1 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 05/21/2004 | CA2503844A1 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2502733A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | CA2502732A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/20/2004 | US20040097743 Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use |
| 05/20/2004 | US20040097594 Sulfonamide inhibitors of aspartyl protease |
| 05/20/2004 | US20040097547 For therapy of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097407 Method for the synthesis of compounds of formula I and their uses thereof |
| 05/20/2004 | US20040097402 Therapy for infections; bactericides; synergistic mixtures |
| 05/20/2004 | US20040096211 Enantioselective reformatsky process for preparing optically active alcohols, amines and derivatives thereof |
| 05/19/2004 | EP1419148A1 M-aminophenol derivatives and colouring agents containing them |
| 05/19/2004 | EP1419147A1 Process for ascorbic acids using alkaline earth silicate catalysts |
| 05/19/2004 | EP1418906A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 05/19/2004 | EP1418900A1 Selective estrogen receptor modulators |
| 05/19/2004 | EP1047664B1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 05/19/2004 | EP0888323B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | DE60003103T2 Substituierte dimere Verbindungen Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen Substituted dimeric compounds process for their preparation and their pharmaceutical compositions |
| 05/19/2004 | DE10250743A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/19/2004 | CN1498215A Process for preparing 5-methylbuty rolactone from levalinic acid |
| 05/19/2004 | CN1498214A Bicyclic guanidine derivatives and therapeutic uses thereof |
| 05/19/2004 | CN1498205A Aryl and biaryl compounds having MCH modulatory activity |
| 05/19/2004 | CN1497048A Method for preparing 3-heteroarylradical-3-hydroxy-propionic acid derivative |
| 05/19/2004 | CN1496999A Solid phase synthesing method of aldehyde, ketonic, oxime amine and isohydroximic acid compound |
| 05/19/2004 | CN1496991A Chirality monophosphorous compound and its transition metal compound |
| 05/19/2004 | CN1496984A Application of 3-hydroxyphenyl phthale compound in preparing culicifuge |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1496740A Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |